Nucleocapsid and Spike Proteins of the Coronavirus SARS-CoV-2 Induce

COVID-19 IL-6 SARS-COV-2 cytokine storm macrophages monocytes

Journal

Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355

Informations de publication

Date de publication:
15 Jan 2021
Historique:
received: 18 12 2020
revised: 11 01 2021
accepted: 12 01 2021
entrez: 20 1 2021
pubmed: 21 1 2021
medline: 21 1 2021
Statut: epublish

Résumé

The pandemic of the new coronavirus SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) has led to the deaths of more than 1.5 million people worldwide. SARS-CoV-2 causes COVID-19, which exhibits wide variation in the course of disease in different people, ranging from asymptomatic and mild courses to very severe courses that can result in respiratory failure and death. Despite the rapid progression of knowledge, we still do not know how individual cells of the immune system interact with the virus or its components, or how immune homeostasis becomes disrupted, leading to the rapid deterioration of a patient's condition. In the present work, we show that SARS-CoV-2 proteins induce the expression and secretion of IL-6 by human monocytes and macrophages, the first line cells of antiviral immune responses. IL-6 may play a negative role in the course of COVID-19 by inhibiting Th1-dependent immunity and stimulating Th17 lymphocytes, thus leading to an increased probability of a cytokine storm.

Identifiants

pubmed: 33467724
pii: vaccines9010054
doi: 10.3390/vaccines9010054
pmc: PMC7830532
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Narodowe Centrum Nauki
ID : 2015/18/E/NZ5/00733

Références

Am J Respir Crit Care Med. 2005 Apr 15;171(8):850-7
pubmed: 15657466
Genome Biol. 2002 Jun 18;3(7):RESEARCH0034
pubmed: 12184808
J Leukoc Biol. 2017 Dec;102(6):1487-1495
pubmed: 28951421
Virus Res. 2009 Jun;142(1-2):19-27
pubmed: 19185596
J Med Virol. 2020 Jul;92(7):755-769
pubmed: 32237160
J Virol. 2009 Apr;83(7):3039-48
pubmed: 19004938
BMJ. 2020 Nov 19;371:m4530
pubmed: 33214134
J Clin Invest. 2020 May 1;130(5):2620-2629
pubmed: 32217835
Lancet Infect Dis. 2013 Sep;13(9):745-51
pubmed: 23782859
Lancet. 2020 Feb 15;395(10223):470-473
pubmed: 31986257
Cell Host Microbe. 2016 Feb 10;19(2):181-93
pubmed: 26867177
Infect Immun. 1996 Mar;64(3):683-90
pubmed: 8641767
J Biol Chem. 1999 Jan 8;274(2):939-47
pubmed: 9873035
Hum Reprod. 2011 May;26(5):1191-201
pubmed: 21357606
Int J Mol Sci. 2018 Sep 18;19(9):
pubmed: 30231586
J Leukoc Biol. 2020 Oct 11;:
pubmed: 33040384
Nat Commun. 2015 Apr 07;6:6702
pubmed: 25850032
Clin Pharmacol Ther. 2020 Nov 18;:
pubmed: 33210302
Front Immunol. 2020 Jun 16;11:1446
pubmed: 32612617
Arthritis Res Ther. 2006;8 Suppl 2:S3
pubmed: 16899107
Nat Commun. 2020 Oct 30;11(1):5493
pubmed: 33127906
Lancet Infect Dis. 2013 Sep;13(9):752-61
pubmed: 23891402
J Immunol Res. 2016;2016:4789279
pubmed: 26885534
Nat Rev Immunol. 2020 Jun;20(6):355-362
pubmed: 32376901
Oncotarget. 2017 Apr 21;8(33):54243-54264
pubmed: 28903338
JCI Insight. 2020 Sep 3;5(17):
pubmed: 32706339
Vaccines (Basel). 2020 Nov 12;8(4):
pubmed: 33198287
JAMA. 2003 Jul 16;290(3):374-80
pubmed: 12865379
Lancet. 2003 Oct 25;362(9393):1353-8
pubmed: 14585636
Life Sci. 2020 Sep 15;257:118102
pubmed: 32687918
Immunity. 2000 Dec;13(6):805-15
pubmed: 11163196
Brief Bioinform. 2020 Oct 09;:
pubmed: 33034338
J Infect. 2020 Jun;80(6):607-613
pubmed: 32283152
Leukemia. 2019 Feb;33(2):536-541
pubmed: 30315231
Arthritis Rheumatol. 2017 Jun;69(6):1135-1143
pubmed: 28217930
Virus Res. 2007 Sep;128(1-2):1-8
pubmed: 17532082
Biomark Res. 2014 Jan 07;2(1):1
pubmed: 24398220
Virology. 2007 Sep 1;365(2):324-35
pubmed: 17490702
Infect Drug Resist. 2020 Jul 22;13:2485-2493
pubmed: 32801787
Inflamm Regen. 2020 Oct 1;40:37
pubmed: 33014208
Lancet Respir Med. 2020 Dec;8(12):1233-1244
pubmed: 33075298
Cytokine. 2021 Feb;138:155365
pubmed: 33246770
Cell Mol Immunol. 2016 Jan;13(1):3-10
pubmed: 26189369
Int J Infect Dis. 2020 Feb;91:264-266
pubmed: 31953166
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Am J Respir Crit Care Med. 2020 Sep 15;202(6):812-821
pubmed: 32584597
PLoS Pathog. 2020 Dec 7;16(12):e1009128
pubmed: 33284859
Sci Immunol. 2020 Jun 5;5(48):
pubmed: 32503877
Science. 2020 Aug 7;369(6504):718-724
pubmed: 32661059
J Exp Med. 2009 Feb 16;206(2):313-28
pubmed: 19204109

Auteurs

Iwona Karwaciak (I)

Laboratory of Transcriptional Regulation, Institute of Medical Biology, Polish Academy of Sciences, 93-232 Lodz, Poland.

Anna Sałkowska (A)

Laboratory of Epigenetics, Institute of Medical Biology, Polish Academy of Sciences, 93-232 Lodz, Poland.

Kaja Karaś (K)

Laboratory of Epigenetics, Institute of Medical Biology, Polish Academy of Sciences, 93-232 Lodz, Poland.

Jarosław Dastych (J)

Laboratory of Cellular Immunology, Institute of Medical Biology, Polish Academy of Sciences, 93-232 Lodz, Poland.

Marcin Ratajewski (M)

Laboratory of Epigenetics, Institute of Medical Biology, Polish Academy of Sciences, 93-232 Lodz, Poland.

Classifications MeSH